Barawkar; Dinesh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barawkar; Dinesh.The latest application filed is for "tricyclic compounds, compositions and medicinal applications thereof".

Company Profile

3.21.20

Barawkar; Dinesh - Mumbia IN
BARAWKAR; Dinesh - Maharashtra Mumbia
Barawkar; Dinesh - Foothill Ranch CA
Barawkar; Dinesh - Pune IN
Barawkar; Dinesh - Hinjewadi Pune IN
Barawkar; Dinesh - Hinjewadi IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tricyclic compounds, compositions and medicinal applications thereof Grant 11,407,758 - Basu , et al. August 9, 2	2022-08-09
Tricyclic Compounds, Compositions And Medicinal Applications Thereof App 20210070764 - BASU; Sujay ; et al.	2021-03-11
1-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine Derivatives And Their Use As Ep4 Receptor Antagonists App 20200339577 - BARAWKAR; Dinesh ; et al.	2020-10-29
1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists Grant 10,745,397 - Barawkar , et al. A	2020-08-18
1-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine Derivatives And Their Use As Ep4 Receptor Antagonists App 20180215754 - BARAWKAR; Dinesh ; et al.	2018-08-02
Derivatives Of N-(arylamino) Sulfonamides As Inhibitors Of Mek App 20170183333 - Maderna; Andreas ; et al.	2017-06-29
Substituted fused tricyclic compounds, compositions, and medicinal applications thereof Grant 9,593,115 - Barawkar , et al. March 14, 2	2017-03-14
Substituted fused pyrimidine compounds Grant 9,284,316 - Palle , et al. March 15, 2	2016-03-15
Substituted Fused Tricyclic Compounds, Compositions, And Medicinal Applications Thereof App 20150239886 - Barawkar; Dinesh ; et al.	2015-08-27
Substituted fused tricyclic compounds, compositions and medicinal applications thereof Grant 9,115,133 - Barawkar , et al. August 25, 2	2015-08-25
Fused tricyclic compounds as adenosine receptor antagonist Grant 9,006,177 - Barawkar , et al. April 14, 2	2015-04-14
Substituted Fused Pyrimidine Compounds App 20150087643 - Palle; Venkata ; et al.	2015-03-26
Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications Grant 8,940,751 - Barawkar , et al. January 27, 2	2015-01-27
Derivatives Of N-(arylamino) Sulfonamides As Inhibitors Of Mek App 20140378466 - Maderna; Andreas ; et al.	2014-12-25
Substituted fused pyrimidine compounds Grant 8,859,566 - Palle , et al. October 14, 2	2014-10-14
Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK Grant 8,829,052 - Maderna , et al. September 9, 2	2014-09-09
Substituted fused pyrimidine compounds, its preparation and uses thereof Grant 8,796,290 - Ramdas , et al. August 5, 2	2014-08-05
Substituted Fused Tricyclic Compounds, Compositions And Medicinal Applications Thereof App 20140023614 - Barawkar; Dinesh ; et al.	2014-01-23
Purine Compounds As Prodrugs Of A2b Adenosine Receptor Antagonists, Their Process And Medicinal Applications App 20130172249 - Barawkar; Dinesh ; et al.	2013-07-04
Substituted Fused Pyrimidine Compounds, Its Preparation And Uses Thereof App 20120225812 - Ramdas; Vidya ; et al.	2012-09-06
Heterocyclic compounds as adenosine receptor antagonist Grant 8,252,797 - Palle , et al. August 28, 2	2012-08-28
Substituted Fused Pyrimidine Compounds App 20120115864 - Palle; Venkata ; et al.	2012-05-10
Derivatives Of N-(arylamino)sulfonamides As Inhibitors Of Mek App 20120022076 - MADERNA; Andreas ; et al.	2012-01-26
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK Grant 8,101,799 - Maderna , et al. January 24, 2	2012-01-24
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK Grant 7,759,518 - Maderna , et al. July 20, 2	2010-07-20
Phenylamino isothiazole carboxamidines as MEK inhibitors Grant 7,652,047 - Abdellaoui , et al. January 26, 2	2010-01-26
Heterocyclic Compounds As Adenosine Receptor Antagonist App 20090298744 - Palle; Venkata ; et al.	2009-12-03
Derivatives Of N-(arylamino) Sulfonamides As Inhibitors Of Mek App 20090082457 - MADERNA; Andreas ; et al.	2009-03-26
Phenylamino Isothiazole Carboxamidines As Mek Inhibitors App 20080306063 - Abdellaoui; Hassan ; et al.	2008-12-11
Phenylamino isothiazole carboxamidines as MEK inhibitors Grant 7,429,667 - Abdellaoui , et al. September 30, 2	2008-09-30
Derivatives Of N-(arylamino) Sulfonamides As Inhibitors Of Mek App 20080058340 - Maderna; Andreas ; et al.	2008-03-06
Phenylamino isothiazole carboxamidines as MEK inhibitors App 20060194802 - Abdellaoui; Hassan ; et al.	2006-08-31
Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections App 20060074035 - Hong; Zhi ; et al.	2006-04-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.